Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
IMPORTANCE: Neuromyelitis optica spectrum disorders (NMOSD) can present with very similar clinical features to multiple sclerosis (MS), but the international diagnostic imaging criteria for MS are not necessarily helpful in distinguishing these two diseases. OBJECTIVE: This multicentre study tested...
Päätekijät: | Juryńczyk, M, Tackley, G, Kong, Y, Geraldes, R, Matthews, L, Woodhall, M, Waters, P, Kuker, W, Craner, M, Weir, A, DeLuca, G, Kremer, S, Leite, M, Vincent, A, Jacob, A, de Sèze, J, Palace, J |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
BMJ Publishing Group
2016
|
Samankaltaisia teoksia
-
Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
Tekijä: Jurynczyk, M, et al.
Julkaistu: (2016) -
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Tekijä: Jurynczyk, M, et al.
Julkaistu: (2017) -
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
Tekijä: Jurynczyk, M, et al.
Julkaistu: (2017) -
RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
Tekijä: Elsone, L, et al.
Julkaistu: (2014) -
Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
Tekijä: Yeo, T, et al.
Julkaistu: (2020)